Bluebird Bio
-
Business
Alphabet, Accenture, Heico, Bluebird Bio, Plug Power, UBS, and More Stock Market Movers
Stock futures traded slightly higher Tuesday, a day after the S&P 500 finished up 0.5% and moved closer to its…
Read More » -
Health
Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved, ET HealthWorld
Bengaluru: Bluebird bio said on Monday it has agreed to sell its priority review voucher for $103 million if it…
Read More » -
Business
The world’s most expensive drug can’t cure what disease This biotechnology
Bluebird Bio is about to become the seller of the two most expensive drugs in the United States, and globally,…
Read More »